Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viliam Lustig

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Chemistry|October 13, 2007
Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptidePeter A Kavsak, Dennis T Ko, Alice M Newman, et al.
Clinical Chemistry|April 1, 2008
Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms?Peter A Kavsak, Alice M Newman, Dennis T Ko, et al.
Clinical Biochemistry|January 16, 2008
Vascular versus myocardial dysfunction in acute coronary syndrome: are the adhesion molecules as powerful as NT-proBNP for long-term risk stratification?Peter A Kavsak, Dennis T Ko, Alice M Newman, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 30, 2007
"Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomesPeter A Kavsak, Dennis T Ko, Alice M Newman, et al.
Clinical Chemistry|March 25, 2006
Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research StudiesAndrew R Macrae, Peter A Kavsak, Viliam Lustig, et al.
American Heart Journal|July 11, 2006
The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarctionPeter A Kavsak, Andrew R MacRae, Viliam Lustig, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 20, 2007
Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarctionPeter A Kavsak, Andrew R MacRae, Alice M Newman, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 3, 2007
Authors' response to Apple editorialPeter A Kavsak, Andrew R MacRae, Viliam Lustig, et al.
Clinical Biochemistry|February 13, 2007
Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failurePeter A Kavsak, Andrew R MacRae, Alice M Newman, et al.
Clinical Chemistry|September 23, 2006
Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of troponin-naïve emergency department patientsPeter A Kavsak, Andrew R MacRae, Glenn E Palomaki, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Chemistry|October 13, 2007
Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptidePeter A Kavsak, Dennis T Ko, Alice M Newman, et al.
Clinical Chemistry|April 1, 2008
Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms?Peter A Kavsak, Alice M Newman, Dennis T Ko, et al.
Clinical Biochemistry|January 16, 2008
Vascular versus myocardial dysfunction in acute coronary syndrome: are the adhesion molecules as powerful as NT-proBNP for long-term risk stratification?Peter A Kavsak, Dennis T Ko, Alice M Newman, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 30, 2007
"Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomesPeter A Kavsak, Dennis T Ko, Alice M Newman, et al.
Clinical Chemistry|March 25, 2006
Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research StudiesAndrew R Macrae, Peter A Kavsak, Viliam Lustig, et al.
American Heart Journal|July 11, 2006
The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarctionPeter A Kavsak, Andrew R MacRae, Viliam Lustig, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 20, 2007
Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarctionPeter A Kavsak, Andrew R MacRae, Alice M Newman, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 3, 2007
Authors' response to Apple editorialPeter A Kavsak, Andrew R MacRae, Viliam Lustig, et al.
Clinical Biochemistry|February 13, 2007
Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failurePeter A Kavsak, Andrew R MacRae, Alice M Newman, et al.
Clinical Chemistry|September 23, 2006
Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of troponin-naïve emergency department patientsPeter A Kavsak, Andrew R MacRae, Glenn E Palomaki, et al.
Pageof 2